Medicenna Therapeutics (TSX: MDNA, OTCQX: MDNAF) is a clinical-stage biotechnology company focused on the development of targeted immunotherapies for the treatment of cancer and immune-mediated diseases. The company's proprietary Superkine platform is designed to...